Persistent HIV Type 1 Seronegative Status Is Associated With Lower CD8+ T-Cell Activation

被引:9
作者
Kuebler, Peter J. [1 ]
Mehrotra, Megha L. [3 ]
Shaw, Brian I. [1 ]
Leadabrand, Kaitlyn S. [1 ]
Milush, Jeffrey M. [1 ]
York, Vanessa A. [1 ]
Defechereux, Patricia [3 ]
Grant, Robert M. [2 ,3 ]
Kallas, Esper G. [5 ]
Nixon, Douglas F. [4 ]
机构
[1] Univ Calif San Francisco, Div Expt Med, San Francisco, CA 94143 USA
[2] Univ Calif San Francisco, Dept Med, San Francisco, CA 94143 USA
[3] Gladstone Inst, Gladstone Inst Virol & Immunol, San Francisco, CA USA
[4] George Washington Univ, Dept Microbiol Immunol & Trop Med, Washington, DC USA
[5] Univ Sao Paulo, Div Clin Immunol & Allergy, BR-05508 Sao Paulo, Brazil
基金
巴西圣保罗研究基金会; 美国国家卫生研究院;
关键词
HIV-1; T-cell activation; HESN; infection risk; IMMUNE ACTIVATION; INFECTION; SUSCEPTIBILITY; PREDICTS; WOMEN; SEX;
D O I
10.1093/infdis/jiv425
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
We leveraged data from the Preexposure Prophylaxis Initiative (iPrEx), a global trial of preexposure chemoprophylaxis against human immunodeficiency virus type 1 (HIV-1) infection, to compare T-cell activation between those who remained negative for HIV-1 and those who became infected during the trial. The frequency of CD38(+)HLA-DR(+)CD8(+)T cells was greater in those who seroconverted, relative to the frequency in those who remained uninfected (1.30% vs 0.82%, respectively; P = .005). This translated to an odds ratio of 4.26 (95% confidence interval, 1.54-11.78) for the association between CD8(+)T-cell activation and infection with HIV-1. T-cell activation may be a biomarker for elevated HIV-1 infection risk.
引用
收藏
页码:569 / 573
页数:5
相关论文
共 15 条
[11]   Early immunologic and virologic predictors of clinical HIV-1 disease progression [J].
Mahnke, Yolanda D. ;
Song, Kaimei ;
Sauer, Mariana M. ;
Nason, Martha C. ;
Giret, Maria Teresa M. ;
Carvalho, Karina I. ;
Costa, Priscilla R. ;
Roederer, Mario ;
Kallas, Esper G. .
AIDS, 2013, 27 (05) :697-706
[12]   CD4+ T-cell activation impairs serogroup C Neisseria meningitis vaccine response in HIV-infected children [J].
Milagres, Lucimar G. ;
Costa, Priscilla R. ;
Santos, Bianca A. N. ;
Silva, Giselle P. ;
Cruz, Aline C. ;
Pereira-Manfro, Wania F. ;
Ferreira, Bianca ;
Barreto, Daniella M. ;
Frota, Ana Cristina C. ;
Kalil, Jorge ;
Hofer, Cristina B. ;
Kallas, Esper G. .
AIDS, 2013, 27 (17) :2697-2705
[13]   Aspirin Attenuates Platelet Activation and Immune Activation in HIV-1-Infected Subjects on Antiretroviral Therapy: A Pilot Study [J].
O'Brien, Meagan ;
Montenont, Emilie ;
Hu, Liang ;
Nardi, Michael A. ;
Valdes, Vanessa ;
Merolla, Michael ;
Gettenberg, Gabrielle ;
Cavanagh, Karen ;
Aberg, Judith A. ;
Bhardwaj, Nina ;
Berger, Jeffrey S. .
JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES, 2013, 63 (03) :280-288
[14]   Low-Level Exposure to HIV Induces Virus-Specific T Cell Responses and Immune Activation in Exposed HIV-Seronegative Individuals [J].
Restrepo, Clara ;
Rallon, Norma I. ;
del Romero, Jorge ;
Rodriguez, Carmen ;
Hernando, Victoria ;
Lopez, Mariola ;
Peris, Alejandra ;
Lozano, Sara ;
Sempere-Ortells, Jose M. ;
Soriano, Vincent ;
Benito, Jose M. .
JOURNAL OF IMMUNOLOGY, 2010, 185 (02) :982-989
[15]   Pre-seroconversion immune status predicts the rate of CD4 T cell decline following HIV infection [J].
van Asten, L ;
Danisman, F ;
Otto, SA ;
Borghans, JAM ;
Hazenberg, MD ;
Coutinho, RA ;
Prins, M ;
Miedema, F .
AIDS, 2004, 18 (14) :1885-1893